LB Pharmaceuticals Inc. (LBRX)

NASDAQ

$38.79

$+2.06

(+5.61%)

Pre-Market

LB Pharmaceuticals Inc. (LBRX) Live Price Chart

Last updated: ⁦2026-10-20 11:09:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

LB Pharmaceuticals Inc. (LBRX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $38.79, with a market capitalization of $1.19B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $14.32 to $50.16. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$1.19B
Open	$36.91
Day's High	$50.16
Day's Low	$13.36
Previous Close	$36.74
Volume	521.22K
Average Volume	393.15K
P/E Ratio	--
52-Week High	$50.16
52-Week Low	$14.32
Dividend Yield	--
Earnings Date	--

LB Pharmaceuticals Inc. (LBRX) Pre-Market Stock Price

LB Pharmaceuticals Inc. (LBRX) is trading at $37.18 in pre-market trading as of 2026-10-19 23:31:00, up 1.21% ($0.44) from the previous close of $36.74

Pre-market trading shows how investors are pricing LBRX before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

LB Pharmaceuticals Inc. (LBRX) 7-Day Stock Price Change

Over the past seven days, LB Pharmaceuticals Inc. (LBRX) moved from $37.22 to $38.79, representing a gain of 4.22% ($1.57).

The stock traded between $33.88 and $40.10 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.

The average daily volume was 583.37 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

LBRX 52-Week Price Position

Position in Range: 68.3%

52W Low$14.32

52W High$50.16

LBRX is currently trading at $38.79, placing it 68.3% of the way from its 52-week low of $14.32 to its 52-week high of $50.16. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is LB Pharmaceuticals Inc. (LBRX)?

LB Pharmaceuticals Inc is a late-stage biopharmaceutical company developing novel therapies for the treatment of a wide range of neuropsychiatric disorders including schizophrenia, bipolar depression, adjunctive treatment of depressive disorder and other diseases. It is building a pipeline that leverages the broad therapeutic potential of its product candidate, LB-102, which it believes has the potential to be the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the United States. LB-102 is currently in late-stage clinical development for schizophrenia and bipolar depression. The company operates as a single reportable segment in the development of novel therapies for the treatment of neuropsychiatric diseases, including schizophrenia.

LB Pharmaceuticals Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	27
Exchange	NASDAQ
Company Website	https://www.lbpharma.us

How to Buy LB Pharmaceuticals Inc. (LBRX) Stock on MEXC

Eligible investors can buy real shares of LB Pharmaceuticals Inc. (LBRX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for LBRX and Place Your Order

Open the RealStocks trading page and search for LBRX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is LB Pharmaceuticals Inc. (LBRX) stock price today?

LB Pharmaceuticals Inc. (LBRX) is currently trading at $ 38.79, up 5.58% ($2.05) from the previous close of $ 36.74. Intraday prices update in real time during regular trading hours.

2.Is LBRX stock going up or down today?

As of 2026-10-19 23:31:00, LBRX is trading at $ 38.79, up 5.58% ($2.05) from its previous close of $ 36.74. The stock has traded between $ 13.36 and $ 50.16 during today’s regular session. Past price movements do not guarantee future results.

3.What is LBRX pre-market price?

As of 2026-10-19 23:31:00, LBRX is trading at $ 37.18 in pre-market trading, up 1.21% ($0.44) from the previous close of $ 36.74. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is LBRX after-hours price?

As of 2026-10-19 23:31:00, LBRX is trading at $ 38.79 in after-hours trading, up 5.58% ($2.05) from the regular-session close of $ 36.74. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is LBRX stock trading now?

LBRX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does LBRX sit relative to its 52-week high and low?

Over the past 52 weeks, LBRX has traded between a low of $ 14.32 and a high of $ 50.16. At $ 38.79, the stock is positioned 68.3% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is LB Pharmaceuticals Inc. in?

LB Pharmaceuticals Inc. (LBRX) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is LB Pharmaceuticals Inc.'s market capitalization and where is it listed?

LB Pharmaceuticals Inc. is listed on the NASDAQ exchange with a market capitalization of $ 1.19B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is LBRX valued in terms of P/E ratio and EPS?

LBRX trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -2.66. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does LB Pharmaceuticals Inc. pay a dividend?

LB Pharmaceuticals Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.